Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific ...

PMI Urges FDA To Renew IQOS MRTP Status, Citing Strong Evidence Of Reduced Harm And Switching

Philip Morris International Inc. (PM) announced that it recently presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC), a panel of independent ...
TipRanks on MSN

Philip Morris urges TPSAC to recommend continued marketing of IQOS as MRTP

International presented evidence to the Tobacco Products Scientific Advisory Committee. The committee, comprised ...
Tbreak

Quitting Cigarettes with Science: PMI’s CEO Jacek Olczak Has a Plan on Going Smoke-Free

PMI CEO Jacek Olczak shares how science, regulation, and consumer behavior must align to achieve a global smoke-free future.

Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product

The FDA granted the MRTP designation to the IQOS system in 2020 for an initial four-year period. The evidence presented to ...

Philip Morris Urges FDA to Back IQOS as Modified Risk Product

The classification was first granted by the FDA in 2020 and allows Philip Morris to tell users that IQOS, a battery-powered device for heating but not burning tobacco, lowers their exposure to harmful ...

Big Tobacco is turning into Big Alternative Nicotine Products — how is that going?

Discover how tobacco giants pivot to alternative nicotine products, driving revenue growth and market outperformance.